News Sentiment

MXCT sentiment intelligence

MaxCyte Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 57 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 1.33 Week of 10 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Earnings

78/100 classification confidence.

Company focus 46

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

+9.5% over one week, +18.7% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

MaxCyte to Report Second Quarter 2026 Financial Results on August 12, 2026

Market Reaction

Price moving ahead of tone

60/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Earnings 78/100 classification
One-week reaction 9.5% Price confirming higher
Trend fit Trend inactive 18.7% over four weeks
Fair value -55.5% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 8
Neutral 44
Negative 5

Relevance

Why the article matched

Direct first
Direct company coverage 46
Industry context 11
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 12
Market source 10
TradingView 9
Moomoo 2
AD HOC NEWS 2
StockStory 2
The Manila Times 1
scanx.trade 1

Event Lens

What the news is about

Classified themes
Earnings 30
Market update 20
Macro sensitivity 2
Guidance 1
Deals and strategy 1
Regulatory and legal 1
Analyst action 1
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-57 of 57
Investing.com Nigeria Direct company coverage

MaxCyte shareholders elect directors and approve auditor at annual meeting By Investing.com

MaxCyte, Inc. held its 2026 annual meeting where shareholders elected three Class II directors—Patrick Balthrop, Cynthia Collins, and Stanley Erck—and ratified CohnReznick LLP as their independent auditor for the fiscal year ending December 31, 2026. Despite the stock being down

Tone
Positive 60/100
Event
Market update
Published
18 Jun 2026 10:09
Source
Investing.com Nigeria
Zacks Investment Research Direct company coverage

Should I buy MaxCyte (MXCT)

Tone
Positive 66/100
Event
Market update
Published
01 Aug 2021 15:54
Source
Zacks Investment Research